Dextran-magnetite particles: contrast-enhanced MRI of blood-brain barrier disruption in a rat model.
Dextran-magnetite particles (DMP) were studied for their use as a MR contrast agent to visualize lesions with a blood-brain barrier (bbb) disruption. A freezing injury to the rat cerebral cortex was used as a model of bbb disruption. The biodistribution of iv-injected DMP was studied using atomic absorption spectrophotometry, electron microscopy, and MRI. One hour after injection, focal accumulation of the particles in capillary endothelial cells could be demonstrated in the freezing lesion. Despite the observation that the relaxivity of DMP in vivo appears to be less well pronounced than that in vitro, the MR imaging studies show that DMP can be used to visualize bbb disruption with adequate contrast.
Bulte
J W
JW
Department of Clinical Immunology, University of Groningen, The Netherlands.
De Jonge
M W
MW
Kamman
R L
RL
Go
K G
KG
Zuiderveen
F
F
Blaauw
B
B
Oosterbaan
J A
JA
The
T H
TH
de Leij
L
L
D000818:Animals; D001812:Blood-Brain Barrier; D002540:Cerebral Cortex / Q000473:pathology*; D003287:Contrast Media; D003911:Dextrans; D005260:Female; D052203:Ferrosoferric Oxide; D007501:Iron; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008854:Microscopy, Electron; D010087:Oxides; D051381:Rats; D011919:Rats, Inbred Strains; D013054:Spectrophotometry, Atomic; D014018:Tissue Distribution
D003287:Contrast Media; D003911:Dextrans; D010087:Oxides; D007501:Iron; D052203:Ferrosoferric Oxide